SCYNEXIS (SCYX) director Ann Hanham receives stock and option grants
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
HANHAM ANN reported acquisition or exercise transactions in this Form 4 filing.
SCYNEXIS director Ann Hanham received new equity awards in the form of common stock and stock options. She was granted 2,875 shares of common stock at no cost and 2,875 stock options with a strike price of $3.85 per share. All 2,875 restricted stock units and all 2,875 options vest in full on the first anniversary of the grant date if she continues serving as a non-employee director. After the stock grant, she directly holds 11,577 shares of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
HANHAM ANN
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 2,875 | $0.00 | -- |
| Grant/Award | Common Stock | 2,875 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 2,875 shares (Direct, null);
Common Stock — 11,577 shares (Direct, null)
Footnotes (1)
- One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. On May 29, 2026, the common stock of the Issuer underwent a 1-for-8 reverse stock split (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split. One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.
Key Figures
RSU grant: 2,875 shares
Option grant: 2,875 options
Option exercise price: $3.85/share
+3 more
6 metrics
RSU grant
2,875 shares
Restricted stock units granted on June 26, 2026
Option grant
2,875 options
Stock options granted on June 26, 2026
Option exercise price
$3.85/share
Conversion or exercise price for 2,875 options
Options expiration
June 25, 2036
Expiration date of granted stock options
Shares held after grant
11,577 shares
Common stock directly owned after grant
Reverse stock split ratio
1-for-8
Reverse split effective May 29, 2026; amounts adjusted
Key Terms
restricted stock unit, reverse stock split, Stock Option (Right to Buy), non-employee director, +1 more
5 terms
restricted stock unit financial
"One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
reverse stock split financial
"the common stock of the Issuer underwent a 1-for-8 reverse stock split"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
non-employee director financial
"provided that the non-employee director is providing continuous services on the applicable vesting date"
expiration date financial
"expiration_date": "2036-06-25T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What did SCYNEXIS (SCYX) director Ann Hanham acquire in this Form 4?
Ann Hanham received 2,875 shares of SCYNEXIS common stock and 2,875 stock options as equity compensation. Both awards are grants, not open-market purchases, reflecting standard non-employee director compensation rather than discretionary trading activity in the company’s shares.
What are the vesting terms of Ann Hanham’s new SCYNEXIS equity awards?
All 2,875 restricted stock units and all 2,875 stock options vest 100% on the first anniversary of the grant date. Vesting requires that she continue providing services as a non-employee director through that one-year vesting date, according to the disclosed terms.
What is the exercise price and expiration for Ann Hanham’s SCYNEXIS stock options?
The granted stock options cover 2,875 shares of SCYNEXIS common stock with a conversion or exercise price of $3.85 per share. These options are scheduled to expire on June 25, 2036, giving a long-term window to exercise once vested.
How did the SCYNEXIS reverse stock split affect the reported amounts in this Form 4?
The filing notes SCYNEXIS completed a 1-for-8 reverse stock split on May 29, 2026. All share and option amounts disclosed in the Form 4, including the 2,875-share grants, have been adjusted to reflect the effects of that reverse stock split event.